Ownership Summary
A total of 10 institutions have reported a stake in Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) as of December 2025, according to recent 13F filings with the SEC.
- These investors collectively held 4.0% of the company's total shares outstanding in December 2025, up from 2.7% in September 2025.
- In percentage terms, this reflects as a holdings change of 60.01% quarter on quarter, and an increase of 11.11% year over year.
- The latest 13F cycle for Creative Medical Technology Holdings reveals that of 10 total investors, 5 funds grew their exposure, whereas 1 reduced theirs and 4 made no changes.
- The total number of shares held by institutions in Creative Medical Technology Holdings increased to 102.83K as of December 2025, a net change of up by 38.56K shares quarter on quarter, and up 72.97K shares year over year.
- With 30.20K shares, JANE STREET GROUP, LLC commands the largest institutional position in Creative Medical Technology Holdings as of December 31, 2025, equating to 1.17% of the company.
- Among the most significant buyers of Creative Medical Technology Holdings during December 2025 were JANE STREET GROUP, LLC (30.20K), Global Retirement Partners, LLC (7.92K), GEODE CAPITAL MANAGEMENT, LLC (5.21K), UBS Group AG (9), Motiv8 Investments LLC (1).
- Leading sellers of Creative Medical Technology Holdings stock in December 2025 included DRW Securities, LLC (4.78K).
- The top 10 institutional holders of Creative Medical Technology Holdings for the quarter ending December 2025 included JANE STREET GROUP, LLC (30.20K), GEODE CAPITAL MANAGEMENT, LLC (28.47K), VANGUARD GROUP INC (25.87K), DRW Securities, LLC (10.32K), Global Retirement Partners, LLC (7.92K), MORGAN STANLEY (34), UBS Group AG (11), TD Waterhouse Canada Inc. (1), SBI Securities Co., Ltd. (1), Motiv8 Investments LLC (1).